Scholar Rock Holding Corp
SRRK · XNASCIK 1727196fmd_1ETAFTZDHNZM1QE90GWBF9PY10Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2017 to Sep 30, 2026, 38 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | 0 | 20 | 15 | 19 | 33 | – | – | 0 |
| Net interest income | 0 | 1 | – | – | – | – | – | – | – |
| Research and development | 20 | 36 | 54 | 74 | 108 | 124 | 122 | 185 | 208 |
| Total operating expenses | 25 | 51 | 75 | 102 | 149 | 168 | 171 | 252 | 385 |
| Operating income | (25) | (51) | (55) | (87) | (130) | (134) | (171) | (252) | (385) |
| Interest expense | – | – | 0 | 0 | 2 | 5 | 7 | 7 | 7 |
| Other non-operating income (expense) | 0 | 1 | 4 | 0 | (2) | (0) | 6 | 6 | 7 |
| Income before taxes | – | – | – | – | – | – | – | – | (378) |
| Net income | (25) | (49) | (51) | (86) | (132) | (135) | (166) | (246) | (378) |